Introducing Quoll Biosciences – Qkine’s new partner in Oceania
Cambridge, UK and Sydney, Australia - Qkine Ltd., a specialist recombinant protein manufacturer and Quoll Biosciences a specialist scientific distributor are pleased to announced their partnership to distribute Qkine high-quality proteins to Australia, New Zealand and Oceania.
Cambridge VC investment surges to $2.3 billion as science-led innovation abounds
Cambridge startups and scaleups raised an impressive $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion.
Xampla’s plant protein microcapsules spotlighted in Royal Society of Chemistry journal
New peer-reviewed research in the Royal Society of Chemistry journal Sustainable Food Technology, shows Xampla’s novel plant protein microcapsules retain oil-based activities through simulated digestion, all the way to the intestinal phase.
Maxion Therapeutics doubles R&D space at Unity Campus after £58 million Series A fundraise
Cambridge - Leading regional property investor and developer Howard Group, is delighted to announce that pioneering biotechnology company Maxion Therapeutics has more than doubled its footprint at Unity Campus.
Astoriom expands global footprint for sample stability storage services
Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions
Closed Loop Medicine appoints Kate Woolland as CEO
Leadership transition to drive commercialization strategy in deploying and scaling proven platform and therapy-specific precision dosing technologies
Wilson Connectivity launches WilsonPro Enterprise 5143U inbuilding cellular repeater for uk market
Wilson Connectivity, a leader in wireless communication technology, recently announced the availability of the WilsonPro Enterprise 5143U in-building cellular repeater for the UK market.
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Lord David Prior appointed as Chair of the Board, previously Chairman of NHS England and member of the UK Life Sciences Council Sir Tony Kouzarides, Co-founder and Director, Milner Therapeutics Institute, and Professor of Cancer Biology, Gurdon Institute, appointed as S
Why SMEs are rethinking their marketing strategy to grow in 2025
The marketing landscape has changed significantly in the past two years, and many SMEs are beginning to take notice. For start-ups and growing businesses focused on R&D, strategy, or business development, marketing can often feel like an afterthought. Yet in today’s digital economy, visibility, engagement, and trust are vital to growth—and those depend on consistent, focused marketing.
Maintaining balance in the immune system: exploring the role of RNA binding proteins in regulatory T cell function
Researchers from the Turner lab at the Babraham Institute have published the first description of the role of the ZFP36 family of RNA binding proteins in regulatory T cells (Tregs).
Arecor establishes partnership with Skye Bioscience to develop enhanced formulation of obesity candidate Nimacimab
Arecor Therapeutics plc, the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces a formulation development collaboration with Skye Bioscience, a clinical-stage biotechnology company focused on obesity and other metabolic health disorders.
Wei Ding joins Salus Wellness
The team writes: We are very pleased to announce that Wei Ding has joined Salus Wellness this month. Wei’s Philosophy: “With persistence and the right support, you can regain control of your health naturally and effectively.”
Genetic ancestry and parental smoking linked to new genetic changes in children
Ancestry and lifestyle choices of parents may affect the rate and type of new genetic changes that arise in their children, new research has found.
Advantages of US manufacturing of telecom equipment
As 5G becomes vital to national infrastructure, U.S.-based production offers security, supply chain control and long-term growth for America’s digital future
Manufacturing the next generation of cellular telecommunications equipment within the United States offers numerous advantages, par
China at Now - An EFEC insight for the UK life sciences community
China’s life sciences sector is undergoing a profound transformation, driven by rapid innovation, deepening global integration, and significant advancements in biopharmaceuticals and medical devices.
Labour boost for GP surgeries in Cambridge
Cambridge patients are set to benefit from thousands more GP appointments as Labour delivers a major cash boost to local surgeries.
Vellos – a company founded by Milner Institute Director Sir Tony Kouzarides – announces partnership with Fifty Years, a renowned pre-seed and seed focused VC firm
Vellos has announced a new partnership with Fifty Years. The partnership will support and inspire the next generation of entrepreneurs across the UK’s deep tech and life sciences sectors.
Senior nurse to bring vast experience to ARU role
Ruth May, England’s former Chief Nursing Officer, joins Anglia Ruskin University.
Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing
World-class experts from bioprocessing and cell and gene therapy (CGT) fields include Phil Vanek PhD, Carl Schoellhammer PhD, Daniel C.
Exploring treatment options for ILD
Interstitial lung disease (ILD) refers to a group of lung disorders that cause inflammation and scarring of lung tissue, leading to progressive breathing difficulties. While there is currently no cure for ILD, treatment focuses on controlling symptoms, slowing disease progression, and improving quality of life. If left untreated, ILD can lead to serious complications and early mortality…
EFEC explores UK-China Life Sciences Synergies at VBEF 2025
At Excellence First Enterprise Consultancy (EFEC), we have dedicated 19 years to forging successful UK-China partnerships, now connecting UK life sciences organisations with opportunities in China and preparing Chinese firms for success in the UK, growing together through shared innovation.
New £4.5million project to boost NHS staffing
Five-year scheme will be led in the East of England by experts from Anglia Ruskin.
Call for glaucoma classification tool to be used nationally
Glaucoma is the most frequent cause of irreversible blindness but up to 40 per cent of patients could be missing out on crucial social support, warn Cambridge experts who hope their free technology will be embraced by clinicians nationally.
